Knopp Biosciences is a drug discovery and development company that focuses on delivering breakthrough treatments in neurological disorders through innovation, experience, and partnership. The company targets diseases imposing high costs on the healthcare system, with patient populations clearly identifiable using validated biomarkers or genetic testing. The company's goal is to accelerate and advance treatment, change the course of diseases, and improve the lives of the patients and their families. Knopp Biosciences was founded in 2004 and is headquartered in Pittsburgh, Pennsylvania.